#Gastrointestinal Stent Market share

[roshankumar7904800]

Gastrointestinal Stents Market

Gastrointestinal Stents Market Size, Share, Trends: Boston Scientific Corporation Lead

Rising adoption of self-expanding metal stents (SEMS) drives market growth

Market Overview:

The Gastrointestinal Stents Market is projected to grow at a CAGR of 5.7% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031. Europe currently dominates the market, with key metrics indicating strong growth in minimally invasive gastrointestinal procedures and an aging population. The market is experiencing significant expansion due to increasing prevalence of gastrointestinal diseases, technological advancements in stent design, and growing preference for minimally invasive procedures.

DOWNLOAD FREE SAMPLE

Market Trends:

The gastrointestinal stents market is witnessing a significant trend towards the adoption of self-expanding metal stents (SEMS). These stents are gaining popularity due to their ability to provide effective and long-lasting relief from various gastrointestinal obstructions. SEMS offer several advantages over traditional plastic stents, including better patency rates, reduced migration risk, and improved patient comfort. The versatility of SEMS in treating both malignant and benign strictures across different segments of the gastrointestinal tract has led to their increased use in clinical practice. This trend is further supported by ongoing innovations in stent materials and designs, which aim to enhance their performance and reduce complications.

Market Segmentation:

Colorectal stents dominate the market, driven by rising incidence of colorectal cancer and bowel obstructions. The colorectal stents segment currently holds the largest market share in the gastrointestinal stents market. This dominance is attributed to the high incidence of colorectal cancer and the increasing use of stents for managing acute malignant colonic obstruction. Colorectal stents offer an effective minimally invasive alternative to emergency surgery, reducing morbidity and improving patient outcomes.

Recent clinical data has shown that the use of colorectal stents as a bridge to surgery in patients with obstructing colorectal cancer can significantly reduce the need for emergency surgeries by up to 80%. The pharmaceutical and medical device industries have been major contributors to the growth of the colorectal stents segment.

Market Key Players:

Boston Scientific Corporation

Cook Medical

Olympus Corporation

ELLA-CS, s.r.o.

Merit Medical Systems, Inc.

Taewoong Medical Co., Ltd.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[willyskristina]

Colonic Stents Market

Colonic Stents Market Size, Share, Trends: Boston Scientific Corporation Leads

Rising Adoption of Smart Technology Propels Market Growth

Market Overview:

The global Colonic Stents Market is estimated to grow at a XX% CAGR between 2024 and 2031. North America now dominates the market, accounting for the vast majority of global sales. Rising colorectal cancer rates, growing usage of minimally invasive procedures, and technological advancements in stent design are among the key metrics. The market for colonic stents is quickly expanding because of the rising prevalence of colorectal illnesses, particularly colorectal cancer. Technological advances in stent materials and designs are improving patient outcomes and increasing the scope of these devices. The shift to minimally invasive procedures, paired with an ageing population, is fuelling market growth.

DOWNLOAD FREE SAMPLE

Market Trends:

The colonic stent market is shifting significantly towards biodegradable and drug-eluting stents. These advanced stents have several advantages over traditional metal stents, including a lower risk of complications and improved long-term outcomes. Biodegradable stents disintegrate in the body over time, eliminating the need for removal procedures and decreasing the risk of stent-related complications. In contrast, drug-eluting stents release medicines locally to prevent restenosis and promote healing. This trend is being driven by an increasing emphasis on patient-centred care and the need for more effective long-term colon disease management. Manufacturers are investing much in research and development to improve the design and functionality of these new stents, providing more options for healthcare providers and patients. As clinical proof for the efficacy of biodegradable and drug-eluting stents grows, so will their utilisation, altering the colonic stents market landscape.

Market Segmentation:

Self-expanding metal stents (SEMS) dominate the product type segment, driven by their superior performance and durability. SEMS offer several advantages over plastic stents, including larger lumen sizes, longer patency periods, and lower migration rates. These advantages have resulted in widespread use in palliative care and bridge-to-surgery applications. Recent developments in SEMS technology have increased its market dominance. For example, Boston Scientific's WallFlex Colonic Stent device, which features a unique flared end design, has produced improved migration rates. A multicenter study published in the journal Gastrointestinal Endoscopy discovered that the WallFlex device had a technical success rate of 98% and a clinical success rate of 87%. Colorectal cancer is driving strong growth in the SEMS industry. The American Cancer Society estimates that 20–25% of colorectal cancer patients have malignant major intestinal blockages. SEMS has emerged as the primary treatment option for these obstructions, especially in patients who are poor surgical candidates or require neoadjuvant therapy before definitive surgery.

Market Key Players:

Boston Scientific Corporation

Cook Medical

Olympus Corporation

ELLA-CS, s.r.o.

Merit Medical Systems, Inc.

M.I. TECH

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[farmacuticals]

Key Drivers and Challenges in the Global Biliary Stents Market

A biliary stent is a medical device used to keep bile ducts open and ensure the flow of bile in patients with obstructions due to conditions such as tumors, strictures, or gallstones. Biliary stent testing is crucial to evaluate the functionality, durability, and biocompatibility of these devices before they are available for clinical use. During testing, factors such as flexibility, tensile strength, and resistance to corrosion are assessed, ensuring the stent performs effectively within the harsh environment of the biliary tract. Testing also includes simulation of in vivo conditions to confirm that the biliary stent can withstand the physiological pressures and chemical interactions without compromising its structure or function.

The biliary stent market was projected to be worth 2.28 billion USD in 2022, according to MRFR analysis. By 2032, the biliary stent market is projected to have grown from 2.43 billion USD in 2023 to 4.2 billion USD. Over the course of the forecast period (2024–2032), the biliary stent market is anticipated to develop at a CAGR of approximately 6.29%.

Biliary Stent Size

Biliary stent size is an important consideration in stent selection, as it affects both the effectiveness and the comfort of the patient. Stents come in a variety of sizes, typically measured in terms of diameter (millimeters) and length (centimeters). The correct biliary stent size depends on the patient's anatomy and the location of the obstruction. An improperly sized stent may lead to migration, blockage, or irritation, which is why accurate sizing is essential for successful treatment outcomes. Advances in stent design have led to the availability of customizable sizes, allowing healthcare professionals to select the most appropriate option for each patient.

Biliary Stent Share

The biliary stent share in the global medical device market has been growing steadily, reflecting an increase in the prevalence of biliary tract diseases and a rise in the elderly population, who are more prone to conditions necessitating stent placement. The growth in biliary stent share is further supported by innovations in stent materials and designs, which improve patient outcomes and reduce complications. Companies that produce biliary stents have been focusing on expanding their market share through product development, collaborations, and expansion into emerging markets. This growth is expected to continue as new technologies in stent manufacturing emerge, enhancing both functionality and ease of placement.

Biliary Stent Analysis

Biliary stent analysis provides detailed insights into the market dynamics, competitive landscape, and key drivers influencing demand. This analysis examines factors such as the increase in gastrointestinal diseases, the aging global population, and technological advancements in minimally invasive procedures. An in-depth biliary stent analysis includes examining the strengths, weaknesses, opportunities, and threats (SWOT) in the biliary stent sector, as well as exploring regional trends, regulatory impacts, and the influence of healthcare policies on market growth. Comprehensive analysis is essential for stakeholders, helping them make informed decisions and strategic investments.

Biliary Stent Trends

The biliary stent industry has seen significant trends shaping its development and adoption. One prominent trend is the shift towards biodegradable and drug-eluting stents, which can reduce the risk of complications like stent occlusion and improve long-term outcomes. Another key trend is the focus on minimally invasive procedures, which allow for easier and safer stent placement. Digital health integration, including imaging guidance for precision stent deployment, is also gaining traction. These biliary stent trends illustrate the industry’s dedication to enhancing patient comfort, reducing complications, and improving overall healthcare efficiency.

Reasons to Buy the Reports

Comprehensive Market Insights: Access to detailed data on biliary stent market dynamics, including size, trends, and share analysis, helps inform investment and business decisions.

Technological Trends: Insight into recent advancements and emerging technologies can guide companies in product development and innovation.

Competitive Landscape: A thorough biliary stent analysis identifies key players, allowing stakeholders to understand their competitive positioning.

Strategic Investment Information: Data-driven insights into potential growth areas support strategic planning and investment.

Regulatory and Policy Updates: Stay informed on global regulatory developments that impact the biliary stent industry.

Recent Developments

Recent advancements in biliary stent technology have focused on improving the materials used, such as employing biodegradable polymers to enhance patient safety. Drug-eluting biliary stents are now available, designed to reduce inflammation and lower the risk of restenosis. Furthermore, digital imaging advancements are aiding in more precise stent placements. Expansion into emerging markets has also been a priority, allowing access to a broader patient base. These developments indicate a dynamic market committed to improving biliary stent efficacy and patient outcomes.

By understanding these aspects, stakeholders can stay updated on the biliary stent market’s evolution and make informed decisions for future engagement.

Related reports:

hpv testing pap test market

infection surveillance solution market

iot medical device market

Top of Form

Bottom of Form

[ravinderimarc]

The global gastrointestinal stents market size reached US$ 433.1 Million in 2023. IMARC Group expects the market to reach US$ 572.5 Million by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.

[globalgrowthinsights]

Pvc Cling Film Market Trends, Demand & Future Scope till 2032

Pvc Cling Film Market provides in-depth analysis of the market state of Pvc Cling Film manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Pvc Cling Film in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Pvc Cling Film Market Report:

The report offers a comprehensive and broad perspective on the global Pvc Cling Film Market.

The market statistics represented in different Pvc Cling Film segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Pvc Cling Film are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Pvc Cling Film.

Major stakeholders, key companies Pvc Cling Film, investment feasibility and new market entrants study is offered.

Development scope of Pvc Cling Film in each market segment is covered in this report. The macro and micro-economic factors affecting the Pvc Cling Film Market

Advancement is elaborated in this report. The upstream and downstream components of Pvc Cling Film and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/pvc-cling-film-market-100586

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Global Mining Explosives MarketMarket Share

Global Rolling Luggage Bags MarketMarket Growth

Floating Production Storage and Offloading (FPSO) MarketMarket

Fundus Cameras MarketMarket Share

Collagen & Gelatin MarketMarket Growth Rate

RFID Printer MarketMarket Forecast

Global Sheet Metal Fabrication Services MarketMarket Size

Online Therapy Services MarketMarket Growth

Dairy Alternative Beverages MarketMarket Analysis

Memory Cards MarketMarket Size

Global CAR T-Cell Therapy MarketMarket Share

Global PCTFE MarketMarket Growth

TOPCon Solar Cell MarketMarket

NGOs and Charitable Organizations MarketMarket Share

Broadband Network Gateway (BNG) MarketMarket Growth Rate

Hyaluronic Acid Based Dermal Fillers MarketMarket Forecast

Global Crypto Asset Management MarketMarket Size

Narrowband IoT (NB-IoT) Chipset MarketMarket Growth

Internet of Things IoT Develop Services MarketMarket Analysis

AI-assisted Diagnosis MarketMarket Size

Global Internet of Things in Retail MarketMarket Share

Global Ginger MarketMarket Growth

Ballast Water Management MarketMarket

Laser Treatment Devices of Varicose Veins MarketMarket Share

LABSA MarketMarket Growth Rate

Human Milk Oligosaccharides MarketMarket Forecast

Global Solar Microinverter and Power Optimizer MarketMarket Size

Digital Experience Platform (DXP) MarketMarket Growth

Glioblastoma Multiforme Treatment MarketMarket Analysis

Frameless Brushless DC Motors MarketMarket Size

Global HSC Milling Machines MarketMarket Share

Global Mobile AB Testing MarketMarket Growth

Gummy Vitamins MarketMarket

Gastrointestinal Stent MarketMarket Share

Automotive HUD MarketMarket Growth Rate

Central Tire Inflation System (CTIS) MarketMarket Forecast

Global Continuous Mixed Flow Dryer MarketMarket Size

Homemade Facial Mask Machine MarketMarket Growth

Public Sector Software MarketMarket Analysis

Private Charging Station for Electric Vehicle MarketMarket Size

[ilmemcmi]

Inflation Devices Market is Owing to Rising Prevalence of Chronic Diseases

Inflation devices are medical instruments that are used in various therapeutic and diagnostic procedures such as angioplasty, colonoscopy and endoscopy. They play a crucial role in widening or dilating the internal passages or cavities of the body. Inflation devices help push open blocked or narrowed blood vessels to improve blood flow and relieve pressure and symptoms. These devices help insert or remove medical devices such as stents, catheters or balloons during surgical procedures. Rising prevalence of cardiovascular diseases, gastrointestinal disorders and respiratory diseases has boosted the demand for various minimally invasive surgeries which in turn is propelling the inflation devices market.

The global inflation devices market is estimated to be valued at US$ 5.35 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031.Key Takeaways Key players operating in the inflation devices market are Bristol-Myers Squibb Co., Bayer AG, Johnson & Johnson Services Inc., Sanofi S.A., Novartis International AG, AstraZeneca plc., Daiichi Sankyo Co Ltd, Boehringer Ingelheim International GmbH, Pfizer Inc., and Merck KGaA. These players are focusing on new product launches, geographical expansions and mergers and acquisitions to strengthen their Inflation Devices Market Growth.

The increasing prevalence of chronic diseases such as cardiovascular diseases, gastrointestinal diseases and obesity has boosted the demand for minimally invasive surgeries worldwide creating significant growth opportunities for players in the inflation devices market.

Key players are expanding their operations in emerging regions of Asia Pacific, Latin America, and Middle East & Africa. Factors such as rising healthcare spending, growing medical tourism, increasing disposable incomes and expanding product portfolios geared towards local requirements are expected to drive the demand for inflation devices in these regions.

Market Drivers

- Rising prevalence of chronic diseases- The increasing incidence of chronic diseases such as cardiovascular diseases, respiratory diseases and gastrointestinal disorders is propelling the demand for therapeutic and diagnostic procedures which require inflation devices.

Market restraints

- Increasing adoption of alternative treatment methods- Alternative treatment methods such as drug therapies and open surgeries are gaining popularity over minimally invasive surgeries reducing the demand for inflation devices in certain therapeutic areas.

- Reimbursement issues- Lack of favorable reimbursement policies for new medical technologies and lack of insurance coverage for minimally invasive procedures in developing nations poses a major challenge for players in the inflation devices market.

Segment Analysis

The Inflation Devices market is dominated by the Disposable Inflation Devices sub segment. Disposable inflation devices are preferred more as they reduce the risk of infection and contamination between patients. Their single use nature ensures sterility which is important in medical procedures. These devices also help avoid the reprocessing costs associated with reusable inflators.

Global Analysis

The North America region holds the largest share in the Inflation Devices market currently. This is owing to factors such as rising prevalence of cardiovascular diseases, growing geriatric population and well developed healthcare system in the region. Availability of advanced medical facilities and reimbursement policies have further boosted the adoption of inflation devices. The Asia Pacific region is expected to grow at the fastest rate during the forecast period. Rising medical tourism industry along with growing healthcare expenditures in developing countries of China and India will drive the demand for inflation devices in the coming years.

Gets More Insights on, Inflation Devices Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[roshankumar7904800]

Biliary Stents Market

Biliary Stents Market Size, Share, Trends: Boston Scientific Corporation Leads

Adoption of Biodegradable Stents Gains Momentum in Biliary Tract Interventions

Market Overview:

The biliary stents market is expected to develop at a CAGR of XX% between 2024 and 2031. The market value is estimated to reach USD XX billion in 2024 and USD YY billion in 2031. North America is expected to lead the market throughout the projection period. Key metrics include the rising prevalence of biliary disorders, technological advances in stent design, and the world's growing elderly population.

The biliary stents market is steadily expanding, owing to rising incidences of biliary tract illnesses, advances in minimally invasive procedures, and increased use of endoscopic techniques. The use of biodegradable materials and drug-eluting technology in stent design is revolutionising biliary obstruction management, resulting in better patient outcomes and fewer problems.

DOWNLOAD FREE SAMPLE

Market Trends:

The biliary stents market is seeing a considerable shift towards the use of biodegradable stents for bile system treatments. These novel stents are intended to gradually disintegrate in the body after their use, avoiding the need for removal procedures and lowering the risk of long-term issues associated with permanent stents. Biodegradable stents provide various benefits, including decreased inflammation, a lower risk of stent migration, and higher long-term patency rates.

A 2023 study in the Journal of Hepatology, for example, found that biodegradable biliary stents reduced stent-related problems by 20% when compared to standard metal stents. Leading medical device firms are investing substantially in R&D to create superior biodegradable materials that can give excellent mechanical support while allowing for regulated disintegration. This trend is driving market innovation, with companies such as Boston Scientific and Cook Medical introducing novel biodegradable stent prototypes in clinical trials, paving the way for a new generation of biliary stents that could significantly improve patient care while also lowering healthcare costs associated with repeat procedures.

Market Segmentation:

Metal stents, particularly self-expanding metal stents (SEMS), have emerged as the dominant segment in the biliary stents market, owing to higher patency rates and better clinical results in the treatment of malignant biliary obstruction. The preference for metal stents is based on significant clinical evidence proving their efficacy and cost-effectiveness in long-term biliary drainage. A study published in the Gastrointestinal Endoscopy journal in 2023 found that metal stents had a 30% longer patency duration than plastic stents in patients with malignant biliary strictures, leading to fewer re-interventions and a higher quality of life.

Metal stent technology has advanced in recent years, solidifying their market leadership. In 2022, Boston Scientific developed the WallFlex Biliary RX Fully Covered Stent, which has a revolutionary anti-migration design and improved conformability to the biliary anatomy. This breakthrough addressed one of the key issues with metal stents, stent migration, and was found to lower migration rates by up to 40% in clinical trials.

Market Key Players:

Boston Scientific Corporation

Cook Medical

Medtronic plc

Olympus Corporation

CONMED Corporation

Taewoong Medical Co., Ltd.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[alicesara611]

A Deep Dive into the Non Vascular Stent Market: Key Players and Strategies By 2022 to 2028

The global non-vascular stents market is expected to grow from US$ 970.6 million in 2022 to US$ 1,326.3 million by 2028, at a CAGR of 5.5%. Non-vascular stents are medical devices used to treat blockages or narrowed passages in various parts of the body, such as the gastrointestinal tract, respiratory tract, and urinary tract. They are made of various materials, such as metal, plastic, and silicone, and are available in a variety of shapes and sizes.

Non-vascular stents are medical devices that are used to treat a variety of non-vascular conditions. They are typically made of metal or plastic and are inserted into the body through a minimally invasive procedure. Non-vascular stents can be used to open up blocked passageways, support weakened structures, or deliver drugs to specific areas of the body.

Get Your Report Sample to Gain Comprehensive Insights! https://bit.ly/3MKbIgD

Market Drivers:

The growth of the non-vascular stents market is being driven by a number of factors, including:

The increasing prevalence of chronic diseases such as cancer, heart disease, and diabetes, which can lead to blockages in various parts of the body.

The rising demand for minimally invasive procedures to treat these diseases.

The technological advancements in non-vascular stents, such as the development of drug-eluting stents and biodegradable stents.

The increasing awareness of non-vascular stents among patients and physicians.

Key Takeaways:

The global non-vascular stents market is expected to grow from US$ 970.6 million in 2022 to US$ 1,326.3 million by 2028, at a CAGR of 5.5%.

The growth of the market is attributed to factors such as the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the growing awareness of non-vascular stents.

The esophageal stent segment is expected to account for the largest share of the market during the forecast period. This is due to the high prevalence of esophageal cancer and the increasing use of esophageal stents for the treatment of this condition.

The North American region is expected to dominate the market during the forecast period. This is due to the high prevalence of chronic diseases and the well-established healthcare system in the region.

Regional Analysis:

North America is the largest market for non-vascular stents, followed by Europe and Asia Pacific. The growth of the North American market is being driven by the high prevalence of chronic diseases and the rising demand for minimally invasive procedures. The growth of the European market is being driven by the increasing awareness of non-vascular stents and the technological advancements in this field. The growth of the Asia Pacific market is being driven by the rising disposable incomes and the increasing demand for healthcare services.

Key Players:

Boston Scientific

COOK MEDICAL

ELLA - CS, s.r.o.

OLYMPUS

B. BRAUN

MEDtronic

Merit Medical Systems, Inc.

H.C.W. Inc.

Biotronik AG

Taewoong Medical Co., Ltd.

ABIOMED, Inc.

Segmentation:

By Product Type:

Esophageal Stents

Biliary Stents

Ureteric Stents

Duodenal Stents

Tracheal Stents

Others

By Application:

Benign Diseases

Malignant Diseases

Others

By Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

[bharat059]

Contract Logistics Market 2023-2031 Increasing Demand With SWOT Analysis and Growth Strategies by Top Companies

Contract Logistics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Contract Logistics industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opportunities and forecasts. The biggest highlight of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19. At the same time, this report analyzed the market of leading 20 countries and introduce the market potential of these countries. “Contract Logistics market was estimated at USD 282542.93 million, and it’s anticipated to reach USD 425815.91 million in 2031, with a CAGR of 4.66% during the forecast years.”

Get a Sample Copy of the Report at –

Segment by Type

Outsourcing

Insourcing

Which growth factors drives the Contract Logistics market growth?

Increasing use of is expected to drive the growth of the Contract Logistics Market.

Segment by Application

Aerospace

Automotive

High-Tech

Pharma & Healthcare

Retail

Others

Market Segment by Region/Country Including: -

North America (United States, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain, etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.)

South America (Brazil, Argentina, Colombia, etc.)

Middle East & Africa (South Africa, UAE, Saudi Arabia, etc.)

For More Related Reports Click Here :

Premium Pram and Baby Stroller Market Share

Ionomer for Construction Industry Growth Report

Gastrointestinal Stent Market Statistics

Work Stress Management Industry Forecast

Stabilizers Used in Antibody Drugs and Vaccines Market Size

Vehicle Retarder Market Share

Medical Billing Outsourcing Market

Hearing Protection Devices Market Trends

Spherical Silica Powder Industry Size

Anionic Dispersants Market Forecast

Burn Treatment Anti-Infectives Products Market Forecast

Semiconductor Packaging And Assembly Equipment Market Revenue

Polybutylene Terephthalate (PBT) Industry Forecast

Electric Vehicles Fuel Cell Industry Growth

Biopharmaceutical CMO and CRO Market Share

Soft Exoskeleton (Exosuits) and Wearable Robots Market Trends

Biopharmaceutical CMO and CRO Market Share

Electronics Adhesives Market Trends

Premium Motorcycle Helmet Market Trends

Microplate Reader Market Trends

[ravinderimarc]

The global gastrointestinal stents market size reached US$ 433.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 572.5 Million by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.

[mysticalfungalaxy]

Non-Vascular Stents Market is expected to be valued at US$ 1.9 billion by 2032 | FMI

The Non-Vascular Stents Market is expected to grow at a CAGR of 4.5% over the anticipated timeframe. (2022 – 2032). In 2022, it is projected that the industry will be worth US$ 1.21 billion, and by 2032, it will be worth US$ 1.9 billion.

The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth.

To learn more about this report @ https://www.futuremarketinsights.com/reports/non-vascular-stents-market

Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient’s safety in jeopardy. Such surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, encouraging many to opt for the same.

Furthermore, patients are less likely to contract hospital-acquired illnesses like bloodstream infections and urinary tract infections if they stay in the hospital for a shorter period of time, in turn, propelling the demand for non-vascular stents.

The most visible and prominent factor spiking the sales of non-vascular stents is a surge in cases of chronic obstructive pulmonary disease (COPD), which is caused by smoking, lung cancer, tracheobronchial malacia, and chemical exposure.

Numerous innovations are taking place in the non-vascular stents market as new medical devices are developed to track gastrointestinal tract, urinary tract, and airway tract.

Non-vascular stents market trends are fostered by rising healthcare spending in developing countries, government and private insurance companies’ helpful medical reimbursement policies, and the proliferation of hospitals and ambulatory surgical centers.

The non-vascular stents market is segmented by product type and by region, where by product type, the market is divided into gastrointestinal stents, pulmonary stents, urological stents, and others.

Non-vascular implants are medical devices designed to keep open and support non-vascular structures within the body. Unlike vascular stents, which are used to treat blockages in blood vessels, non-vascular stents are used to treat a variety of conditions in other parts of the body.

Key Takeaways:

Based on product type, the urological stents segment is likely to dominate the non-vascular stents market with a CAGR of 4.3% through 2032.

The US non-vascular stents market is expected to capture a sizeable non-vascular stents market share accounting for around US$659.1 million by 2032.

By 2032, the UK non-vascular stents market is expected to be valued at US$ 80.6 million, growing at a CAGR of 3.3%.

With a CAGR of 3.6% during the forecast period, China non-vascular stents market size is predicted to be apprised at US$ 128.1 million by 2032.

The Japan non-vascular stents market, with a CAGR of 3.9%, is projected to garner a worth of US$ 109.8 million by 2032.

Key Players:

Medtronic plc.

Glaukos Corporation

Boston Scientific Corporation

ELLA – CS, s.r.o.

CONMED Corporation

Key Segments

By Product:

Gastrointestinal Stents

Biliary

Duodenal

Colonic

Pancreatic

Oesophageal Stents

Pulmonary Stents

Silicone Airway

Metallic Airway

Urological Stents

Others